Progress on drug treatment of acute respiratory distress syndrome
10.3760/cma.j.issn.1673-4912.2022.10.002
- VernacularTitle:急性呼吸窘迫综合征的药物治疗进展
- Author:
Jiangwen YIN
1
;
Hongjun MIAO
Author Information
1. 南京医科大学附属儿童医院急重症医学科 210008
- Keywords:
Acute respiratory distress syndrome;
Children;
Drug therapy
- From:
Chinese Pediatric Emergency Medicine
2022;29(10):764-767
- CountryChina
- Language:Chinese
-
Abstract:
Acute respiratory distress syndrome(ARDS) refers to non-cardiac respiratory failure caused by various internal and external factors in the lung, and is a common clinical critical illness.As in adults, lung-protective ventilation strategies combined with pharmacological support remain the mainstay of treatment for children with ARDS.A large number of clinical studies have been carried out on drug therapy, and some progress has been made.This article reviewed alveolar surfactants, hormones, nitric oxide, angiotensin converting enzyme 2, immune nutrition, etc., in order to provide references for subsequent treatment.
